HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

Haleon plc (HLN) Stock Price, Analysis & Trade Signals

$8.96+0.05 (+0.56%)

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon pl…

Market Cap
$44.83B
CEO
Brian James McNamara
Employees
24,561
IPO Date
2022-07-25
Website
www.haleon.com

Tabs · Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics